| Literature DB >> 22350798 |
Karla R Kaun1, Anita V Devineni, Ulrike Heberlein.
Abstract
Animal studies have been instrumental in providing knowledge about the molecular and neural mechanisms underlying drug addiction. Recently, the fruit fly Drosophila melanogaster has become a valuable system to model not only the acute stimulating and sedating effects of drugs but also their more complex rewarding properties. In this review, we describe the advantages of using the fly to study drug-related behavior, provide a brief overview of the behavioral assays used, and review the molecular mechanisms and neural circuits underlying drug-induced behavior in flies. Many of these mechanisms have been validated in mammals, suggesting that the fly is a useful model to understand the mechanisms underlying addiction.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22350798 PMCID: PMC3351628 DOI: 10.1007/s00439-012-1146-6
Source DB: PubMed Journal: Hum Genet ISSN: 0340-6717 Impact factor: 4.132
Fig. 1Common genetic tools in Drosophila. a The Gal4/UAS system (Brand and Perrimon 1993). The transcriptional activator Gal4 is expressed in a spatially restricted pattern and activates any gene placed downstream of the upstream activating sequence (UAS). b The TARGET system (McGuire et al. 2003). At the restrictive temperature (30°C), Gal80ts is inactive, Gal4 is active and UAS-driven genes are expressed. At the permissive temperature (19°C), Gal80ts is active, Gal4 is inhibited, and UAS-driven genes are not expressed. c The Shibirets system (Kitamoto 2001). At the restrictive temperature (30°C), but not the permissive temperature (19°C), Shits blocks neurotransmission by disrupting endocytosis and thereby depleting synaptic vesicles. d The TrpA1 system (Hamada et al. 2008; Pulver et al. 2009). At the restrictive temperature (27°C), but not the permissive temperature (19°C), cation flow through the temperature-gated cation channel dTRPA1 causes neuronal depolarization
Fig. 2Assays to measure alcohol-induced behavior in Drosophila. a The inebriometer measures ethanol-induced loss of postural control by measuring the time required for flies to fall down the mesh baffles from the top to the bottom of the column (Weber 1988; Moore et al. 1998). b The booz-o-mat allows for the measurement of ethanol-induced hyperactivity and sedation while streaming vaporized ethanol into horizontal tubes containing groups of flies. Hyperactivity is measured by filming the flies and using tracking software to calculate their locomotor speed. Sedation is measured by recording the time required for flies to exhibit the loss-of-righting reflex (Wolf et al. 2002). c The two-choice CAFE assay measures consumption preference for food containing ethanol compared to normal food (Ja et al. 2007; Devineni and Heberlein 2009). d Conditioned ethanol preference is measured by training the flies in a sealed container to associate a neutral odor with the presence of an intoxicating dose of ethanol, and later testing preference for that odor in the absence of ethanol using a Y-maze (Kaun et al. 2011)
Selected genes mediating ethanol-induced behaviors in flies
| Gene | Mechanism of action | Ethanol-related phenotype | Reference | Homolog validated in mammals |
|---|---|---|---|---|
|
| cAMP pathway | Increased motor impairment | Moore et al. ( | Wand et al. ( |
|
| Inhibits EGFR pathway | Decreased sedation | Corl et al. ( | |
|
| EGFR/Erk pathway | Increased sedation | Corl et al. ( | Corl et al. ( |
|
| EGFR and PI3K/Akt pathways; regulation of synapse number | Increased sedation | Eddison et al. ( | |
|
| Tor pathway; regulation of synapse number | Increased sedation (upon overexpression) | Eddison et al. ( | |
|
| Notch pathway? | Decreased conditioned preference | Kaun et al. ( | |
|
| Transcriptional regulation of | Increased sedation | Lasek et al. ( | Lasek et al. ( |
|
| Receptor tyrosine kinase signaling | Decreased sedation | Lasek et al. ( | Lasek et al. ( |
|
| Stress pathway; regulation of synapse number? | Decreased tolerance | Scholz et al. ( | Riley et al. ( |
|
| Stress pathway; regulation of microtubules? | Decreased tolerance | Li et al. ( | |
|
| Regulation of translation? Actin regulation? | Decreased sedation; decreased tolerance; decreased ethanol consumption | Berger et al. ( | |
|
| Regulation of Tau/microtubules through par-1 | Decreased hyperactivity | King et al. ( | |
|
| Regulation of Rho family GTPases; actin regulation? | Decreased sedation | Rothenfluh et al. ( | |
|
| Integrin/cell adhesion | Increased motor impairment; increased tolerance | Bhandari et al. ( | |
|
| Integrin/cell adhesion | Increased motor impairment; increased tolerance | Bhandari et al. ( | |
|
| Synaptic transmission | Decreased tolerance | Krishnan et al. ( | |
|
| Synaptic transmission | Decreased tolerance | Krishnan et al. ( | |
|
| Synaptic transmission | Increased tolerance | Godenschwege et al. ( | |
|
| Postsynaptic signaling | Increased sedation; decreased tolerance | Urizar et al. ( | Szumlinski et al. ( |
|
| GABA signaling | Decreased sedation | Dzitoyeva et al. ( | Zaleski et al. ( |
|
| Calcium-activated potassium channel activity | Decreased tolerance | Cowmeadow et al. ( | Knott et al. ( |
|
| Dopamine synthesis | Decreased hyperactivity | Bainton et al. ( | Friedhoff and Miller ( |
|
| Dopamine signaling | Decreased hyperactivity | Kong et al. ( | El Ghundi et al. ( |
|
| Octopamine synthesis | Decreased tolerance | Scholz et al. ( | Tabakoff and Ritzmann ( |
|
| Insulin signaling | Increased sedation | Corl et al. ( | |
|
| NPF signaling | Decreased sedation | Wen et al. ( | Thiele et al. ( |
This table includes the genes referred to in the text, which represent many of the genes that have been functionally characterized as regulators of ethanol-induced behavior. We have not included every gene that has been identified, but we have made an effort to include representative genes for each signaling pathway or general mechanism. Studies identifying a large number of genes with limited characterization of mechanism (e.g. Berger et al. 2008) have not been included. In cases where many genes in the same signaling pathway have been implicated, the gene initially identified is listed and the signaling pathway is described in the second column (e.g. aru, PI3K/Akt pathway). Unless otherwise specified, the ethanol-related phenotype described in the third column refers to the phenotype upon impairing the function of the gene product by mutation, RNAi, or pharmacology
Genes mediating drug-related behaviors in flies (excluding ethanol)
| Gene | Mechanism of action | Drug-related phenotype | Reference | Homolog validated in mammals |
|---|---|---|---|---|
|
| Dopamine synthesis | Decreased sensitivity to cocaine and nicotine (using drug inhibitor) | Bainton et al. ( | Pradhan ( |
|
| Monoamine storage and release | Reduced cocaine-induced hyperactivity | Chang et al. ( | Brown et al. ( |
|
| Regulation of circadian rhythms | Reduced behavioral sensitization to cocaine | Andretic et al. ( | Abarca et al. ( |
|
| Development and permeability of blood–brain barrier | Increased sensitivity to cocaine | Bainton et al. ( | |
|
| Functions with | Reduced sensitivity to cocaine | Bainton et al. ( | Bishop et al. ( |
|
| Regulates actin cytoskeleton? | Reduced sensitivity to cocaine and nicotine | Rothenfluh et al. ( | |
|
| Regulates dopamine receptor expression? | Increased sensitivity to cocaine and nicotine | Tsai et al. ( | Lasek et al. ( |
|
| Mushroom body development; regulates microtubules? | Reduced sensitivity to cocaine and nicotine | King et al. ( |
The drug-related phenotype refers to the phenotype upon impairing the function of the gene product